Acute Coronary Syndromes
Conference Coverage
VIDEO: Novel drug misses mark for MI prevention, but shows promise
Conference Coverage
VIDEO: Study of hs-cTnT in chest pain intriguing, but flawed
Conference Coverage
'Revolutionary' LDL lowering shown in evolocumab phase III trials
News
RAS blocker prescriptions still lag for ACS patients
Major Finding: Only 85% of ACS patients who met class I criteria and 69% who met class IIa criteria were discharged with an ACE inhibitor or ARB...
News
USPSTF: Insufficient evidence to judge vitamin supplements
Major Finding: Current evidence is still insufficient to recommend for or against the use of multivitamins, individual vitamins and minerals, or...